SLC-391 , CAS No.1783825-18-2, Inhibitor of AXL receptor tyrosine kinase;Inhibitor of MER proto-oncogene; tyrosine kinase;Inhibitor of TYRO3 protein tyrosine kinase

Item Number

S613619

Grouped product items
SKU	Size	Availability	Price	Qty
S613619-5mg	5mg	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$570.90
S613619-25mg	25mg	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$2,000.90

View related series

Basic Description

Synonyms	SLC391\|SLC-391\|SLC0211\|SLC-0211\|DSP7A26K25\|SLC-391 [WHO-DD]\|UNII-DSP7A26K25\|1783825-18-2\|2-Pyridinamine, 3-(5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-\|3-(5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-yl)-5-(1-(4-piperidin
Grade	Moligand™
Action Type	INHIBITOR
Mechanism of action	Inhibitor of AXL receptor tyrosine kinase;Inhibitor of MER proto-oncogene; tyrosine kinase;Inhibitor of TYRO3 protein tyrosine kinase

Associated Targets

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Names and Identifiers

IUPAC Name	3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
INCHI	InChI=1S/C19H23N7O/c20-18-16(19-25-24-17(27-19)7-12-1-2-12)8-13(9-22-18)14-10-23-26(11-14)15-3-5-21-6-4-15/h8-12,15,21H,1-7H2,(H2,20,22)
InChi Key	JYVSYFGHYFXYBE-UHFFFAOYSA-N
Canonical SMILES	C1CC1Cc1nnc(o1)c1c(ncc(c1)c1cn(nc1)C1CCNCC1)N
Isomeric SMILES	C1CC1CC2=NN=C(O2)C3=C(N=CC(=C3)C4=CN(N=C4)C5CCNCC5)N
PubChem CID	118110201

PubChem CID

CAS Registry No.

Solution Calculators

Determine the necessary mass, volume, or concentration for preparing a solution.

Determine the dilution needed to prepare a stock solution.

Basic Description